SELLAS Life Sciences Group (SLS) Stock Forecast & Price Target
Score
SELLAS Life Sciences Group, Inc. price target
| SLS | |
|---|---|
| Low | $35.00 |
| Average | $35.00 |
| High | $35.00 |
The average published target is $35.00.
SELLAS Life Sciences Group, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 1 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Strong Buy |
2 analysts cover SLS.
Is SELLAS Life Sciences Group, Inc. a buy or sell?
Of the 2 analysts covering SELLAS Life Sciences Group, Inc., 2 rate it a buy (1 strong buy and 1 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The SLS consensus label is Strong Buy, beside 2 buy-side ratings and 0 sell-side ratings.
The average target on file is $35.00.
The SLS rating block is 2 published views with a Strong Buy label. It does not tell you whether to buy or sell.
Reading the SELLAS Life Sciences Group, Inc. forecast
the SELLAS Life Sciences Group, Inc. has a tight target cluster: $35.00 to $35.00, average $35.00.
The SLS rating mix is lopsided rather than split: 2 of 2 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Strong Buy.
With 2 analysts on SLS, the average is a small sample.
SELLAS Life Sciences Group, Inc. forecast questions
What is the SLS price target?
The published range for SLS is $35.00 to $35.00, with an average of $35.00.
Is SELLAS Life Sciences Group, Inc. a buy or sell?
Of the 2 analysts covering SELLAS Life Sciences Group, Inc., 2 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Strong Buy, leaving SLS at 2 buy ratings, 0 holds, and 0 sells.
What is the EPS estimate for SELLAS Life Sciences Group, Inc.?
No EPS estimate for the next two fiscal years is on file for SELLAS Life Sciences Group, Inc..
What is the revenue estimate for SELLAS Life Sciences Group, Inc.?
No revenue estimate for the next two fiscal years is on file for SELLAS Life Sciences Group, Inc..
How many analysts cover SLS?
2 analysts cover SLS. Their consensus on SLS is Strong Buy, across those 2.